Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology.
Driscoll
David F
DF
Division of Clinical Nutrition, Beth Israel Deaconess Medical Center and Harvard Medical School, 185 Pilgrim Road, Suite 605, Boston, MA 02215, USA. ddriscol@bidmc.harvard.edu
Bistrian
Bruce R
BR
Demmelmair
Hans
H
Koletzko
Berthold
B
D004305:Dose-Response Relationship, Drug; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use*; D005227:Fatty Acids / Q000008:administration & dosage / Q000378:metabolism; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena / Q000502:physiology*; D007231:Infant, Newborn; D007234:Infant, Premature / Q000254:growth & development* / Q000378:metabolism; D007363:Intensive Care Units, Neonatal; D015227:Lipid Peroxidation / Q000187:drug effects; D010288:Parenteral Nutrition / Q000379:methods*; D010316:Particle Size; D014280:Triglycerides / Q000008:administration & dosage
D005217:Fat Emulsions, Intravenous; D005227:Fatty Acids; D014280:Triglycerides